Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02720211 · ClinicalTrials.gov registry record · NA
Spectacle Tints and Thin-Films for Migraine
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02720211: Clinical Trial NA study, sponsored by University of Utah.
NCT02720211 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02720211, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Nearly all migraine sufferers report sensitivity to light during a headache and a significant proportion of sufferers report light sensitivity between attacks. Light is also a common trigger for migraine headaches. Spectacle lenses that have been treated with tints and spectacle lenses that have been treated with thin-films have both been shown to reduce light sensitivity and headache in patients with migraine. At this time, it is not clear which spectacle lens treatment is superior. The purpose of this trial is to determine if there's a significant, therapeutic advantage to either spectacle lens treatment. Both treatments could be a novel, non-invasive adjuvant in the treatment of migraine.
Primary Outcome
average number of days (in one month) with at least one headache lasting at least 4 hours
Interventions
- DEVICE Gray tinted spectacle lenses
- DEVICE Thin-Film spectacle lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-11-06 |
| Phase | NA |
Why NCT02720211 stopped before completion
NCT02720211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Gray tinted spectacle lenses is the first listed.
NCT02720211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02720211 about?
NCT02720211 is a clinical study titled "Spectacle Tints and Thin-Films for Migraine". Nearly all migraine sufferers report sensitivity to light during a headache and a significant proportion of sufferers report light sensitivity between attacks. Light is also a common trigger for migraine headaches. Spectacle lenses that have been treated with tints and spectacle lenses that have bee...
What is the current status of trial NCT02720211?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2016-08. Estimated completion is 2018-11-06.
What interventions are being tested in trial NCT02720211?
The interventions under investigation include: Gray tinted spectacle lenses (DEVICE), Thin-Film spectacle lenses (DEVICE).
Who is sponsoring clinical trial NCT02720211?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02720211's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia